<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
Terence O'Dwyer

Terence O'Dwyer

LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Posts by Terence O'Dwyer

Outlook, investment & challenges facing UK CEOs - ...

During the recent HealthEx London forum at One George Street, Westminster, ...

Read More

What can the CEO of Redx Pharma tell us about attr...

During the recent HealthEx London forum at One George Street, Westminster, ...

Read More

How one cell therapy company is driving a paradigm...

What you will learn by reading this post: How Ajan Reginald, CEO, Cell Ther...

Read More

How to make a £3bn life science company

What you will learn by reading this post: How Jim Phillips, CEO, Midatech P...

Read More

5 unique insights from the man at the helm of UK l...

Imperial Innovations has recently released its HY results, and I had the op...

Read More

5 Fundamental Drivers for European Life Science Co...

At the recentBiotech and Money London 2015 event,we pulled together some of...

Read More

3 home truths I learned about the future of life s...

The keynote session at Biotech and Money London convened some of the leader...

Read More

9 things I learned from JP Morgan's Executive Dire...

JP Morgan is the leading investment bank in the life science sector assisti...

Read More

The 2 biggest challenges facing Roche's vision of ...

The opportunities in personalised medicine and personalised healthcare have...

Read More

Biotech and Money London Post Event Report

In February 2015 Biotech and Money London welcomed over 270 life science ex...

Read More

13 bright ideas and opportunities you will learn a...

In just under two weeks, over 250 biotech CEOs, pharma execs, investors and...

Read More

5 Fundamental Life Science and Biotech Focus Areas...

Ahead of next month's keynote panel on the future of life science investmen...

Read More

Add Your Response